Question 1

What is LERODALCIBEP-LIGA used for?

Accepted Answer

LERODALCIBEP-LIGA (brand name LEROCHOL) is a Other indicated for 1 INDICATIONS AND USAGE LEROCHOL TM is indicated as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C) in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia (HeFH). ( 1 ).

Question 2

How does LERODALCIBEP-LIGA work?

Accepted Answer

LERODALCIBEP-LIGA works through the following mechanism: 12.1 Mechanism of Action Lerodalcibep-liga is a recombinant fusion protein that binds PCSK9 with picomolar affinity. PCSK9 binds to low-density lipoprotein receptor (LDLR) on the surface of hepatocytes to promote LDLR degradation within the liver. By inhibiting the binding of PCSK9 to LDLR, lerodalcibep-liga increases the number of LDLRs available to clear LDL-C from the blood, thereby lowering LDL-C levels. [see Clinical Pharmacology ( 12.3 )] ..

Question 3

What are the most common side effects of LERODALCIBEP-LIGA?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for LERODALCIBEP-LIGA. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is LERODALCIBEP-LIGA the same as LEROCHOL?

Accepted Answer

LEROCHOL is a brand name for LERODALCIBEP-LIGA. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

LERODALCIBEP-LIGA

Mechanism of Action

Indications

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations